3 results  1 of 1 

1 Prevalence and Prognostic Role of PIK3CA/AKT1 Mutations in Chinese Breast Cancer Patients
Ling Deng, Xuehua Zhu, Yun Sun, Jiemin Wang, Xiaorong Zhong, Jiayuan Li, Min Hu, Hong Zheng
Cancer Res Treat.2019;51(1):128-140.   Published online 2018 March 15     DOI: http://dx.doi.org/10.4143/crt.2017.598
      
2 A Novel, Potent, Small Molecule AKT Inhibitor Exhibits Efficacy against Lung Cancer Cells In Vitro
Saketh S. Dinavahi, Rajagopalan Prasanna, Sriram Dharmarajan, Yogeeswari Perumal, Srikant Viswanadha
Cancer Res Treat.2015;47(4):913-920.   Published online 2015 January 2     DOI: http://dx.doi.org/10.4143/crt.2014.057
      
3 Aerosol delivery of kinase-deficient Akt1 attenuates Clara cell injury induced by naphthalene in the lungs of dual luciferase mice
Arash Minai-Tehrani, Young-Chan Park, Soon-Kyung Hwang, Jung-Taek Kwon, Seung-Hee Chang, Sung-Jin Park, Kyeong-Nam Yu, Ji-Eun Kim, Ji-Young Shin, Ji-Hye Kim, Bitna Kang, Seong-Ho Hong, Myung-Haing Cho
J Vet Sci.2011;12(4):309-317.   Published online 2011 November 30     DOI: http://dx.doi.org/10.4142/jvs.2011.12.4.309
      

 1 of 1